Jasper Therapeutics, Inc.
JSPRW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001788028
No open-market purchases or sales by Jasper Therapeutics, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $187.1K in total; no superinvestor holds it.
Other share classesJSPR
13F holders, Q1 2023
Institutional positions in Jasper Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- −4 vs. Q4 2022
- Shares held
- 2.03M
- +718.7K (+54.8%) vs. Q4 2022
- Total value
- $430.9K
- +$375.5K (+676.9%) vs. Q4 2022
- New holders
- 1
- 2 more added
- Sold out
- 5
- 2 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JSPRW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $187.1K |
| Q1 2026 | 8 | $371.6K |
| Q4 2025 | 10 | $761.1K |
| Q3 2025 | 9 | $1.09M |
| Q2 2025 | 7 | $383.1K |
| Q1 2025 | 6 | $129.0K |
| Q4 2024 | 5 | $193.1K |
| Q3 2024 | 5 | $625.7K |
| Q2 2024 | 5 | $618.9K |
| Q1 2024 | 4 | $538.5K |
| Q4 2023 | 6 | $236.3K |
| Q3 2023 | 8 | $120.7K |
| Q2 2023 | 11 | $344.6K |
| Q1 2023 | 11 | $430.9K |
| Q4 2022 | 15 | $55.5K |
| Q3 2022 | 15 | $135.0K |
| Q2 2022 | 15 | $179.0K |
| Q1 2022 | 16 | $554.0K |
| Q4 2021 | 16 | $2.97M |
| Q3 2021 | 16 | $3.67M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Jasper Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cowen and Company, LLC | 661,016 | $132.2K | 0.02% | +628,426+1,928.3% | Added |
| Walleye Capital LLC | 654,834 | $131.0K | 0.00% | +629,775+2,513.2% | Added |
| Ionic Capital Management LLC | 257,943 | $51.6K | 0.02% | −201,448−43.9% | Reduced |
| Tenor Capital Management Co., L.P. | 250,000 | $50.0K | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | – | $26.0K | 0.00% | – | – |
| CSS LLC | 81,957 | $16.4K | 0.00% | +81,957 | New |
| Zazove Associates LLC | 65,456 | $12.0K | 0.00% | 00.0% | Unchanged |
| Equitec Proprietary Markets, LLC | 44,856 | $8.97K | 0.01% | −1,000−2.2% | Reduced |
| Walleye Trading LLC | 14,095 | $2.82K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 50 | $10 | 0.00% | 00.0% | Unchanged |
| SkyView Investment Advisors, LLC | 302 | $0 | 0.00% | 00.0% | Unchanged |
| Owl Creek Asset Management, L.P. | 0 | $0 | 0.00% | −267,189−100.0% | Sold out |
| Privium Fund Management B.V. | 0 | $0 | 0.00% | −98,202−100.0% | Sold out |
| Shaolin Capital Management LLC | 0 | $0 | 0.00% | −20,420−100.0% | Sold out |
| Wolverine Asset Management LLC | 0 | $0 | 0.00% | −10,646−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −22,524−100.0% | Sold out |